HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yael Yaniv Selected Research

Polymorphic catecholergic ventricular tachycardia

1/2017SK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmias.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yael Yaniv Research Topics

Disease

1COVID-19
01/2022
1Bradycardia
01/2022
1Heart Failure
01/2022
1Reperfusion Injury
01/2022
1Polymorphic catecholergic ventricular tachycardia
01/2017
1Tachycardia (Tachyarrhythmias)
01/2016
1Cardiovascular Diseases (Cardiovascular Disease)
07/2012
1Neoplasms (Cancer)
07/2012
1Infarction (Infarctions)
06/2009
1Tetanus
10/2006

Drug/Important Bio-Agent (IBA)

1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2022
1Adenosine Triphosphate (ATP)IBA
01/2022
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2022
1LigandsIBA
01/2022
1KATP ChannelsIBA
01/2022
1CalsequestrinIBA
01/2017
1Cyclic NucleotidesIBA
01/2016
1IvabradineIBA
07/2012
1MicroRNAs (MicroRNA)IBA
07/2012
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
06/2009
1Oxidants (Oxidizing Agents)IBA
06/2009
1cyclopiazonic acidIBA
10/2006